Hollow hydroxyapatite microsphere: a promising carrier for bone tissue engineering

References

• Allgrove J. Biphosphonates. Arch Dis Child, 1997;76:73–5.
   PubMed Web of Science ®Google Scholar
• Boanini E, Gazzano M, Rubini K, Bigi A. Composite nanocrystals provide new insight on alendronate interaction with hydroxyapatite structure. Adv Mater, 2007;19:2499–502.
   Web of Science ®Google Scholar
• Boanini E, Torricelli P, Gazzano M, Giardino R, Bigi A. Alendronate–hydroxyapatite nanocomposites and their interaction with osteoclasts and osteoblast-like cells. Biomaterials, 2008;29:790–6.
   PubMed Web of Science ®Google Scholar
• Correia Vde FP, Caldeira CL, Marques MM. Cytotoxicity evaluation of sodium alendronate on cultured human periodontal ligament fibroblasts. Dent Traumatol, 2006;22:312–17.
   PubMed Web of Science ®Google Scholar
• Cramer J, Gold D, Silverman S, Lewiecki E. A systematic review of persistence and compliance with bisphosphonates for osteoporosis. Osteoporos Int, 2007;18:1023–31.
   PubMed Web of Science ®Google Scholar
• Ebetino F, Francis M, Rogers M, Russell R. Mechanisms of action of etidronate and other bisphosphonates. Rev Contemp Pharmaco, 1998;9:233–43.
   Google Scholar
• Eriksen EF, Charles P, Melsen F, Mosekilde L, Risteli L, Risteli J. Serum markers of type I collagen formation and degradation in metabolic bone disease: Correlation with bone histomorphometry. J Bone Miner Res, 1993;8:127–32.
   PubMed Web of Science ®Google Scholar
• Garcia-Moreno C, Serrano S, Nacher M, Farre M, Diez A, Marinoso M, Carbonell J, Mellibovsky L, Nogues X, Ballester J. Effect of alendronate on cultured normal human osteoblasts. Bone, 1998;22:233–9.
   PubMed Web of Science ®Google Scholar
• Halvorsen YDC, Franklin D, Bond AL, Hitt DC, Auchter C, Boskey AL, Paschalis EP, Wilkison WO, Gimble JM. Extracellular matrix mineralization and osteoblast gene expression by human adipose tissue-derived stromal cells. Tissue Eng, 2001;7:729–41.
   PubMedGoogle Scholar
• Hughes DE, Wright KR, Uy HL, Sasaki A, Yoneda T, Roodman DG, Mundy GR, Boyce BF. Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J Bone Miner Res, 1995;10:1478–87.
   PubMed Web of Science ®Google Scholar
• Josse S, Faucheux C, Soueidan A, Grimandi G, Massiot D, Alonso B, Janvier P, Laïb S, Gauthier O, Daculsi G. Chemically modified calcium phosphates as novel materials for bisphosphonate delivery. Adv Mater, 2004;16:1423–7.
   Web of Science ®Google Scholar
• Komori T. Regulation of osteoblast differentiation by transcription factors. J Cell Biochem, 2006;99:1233–9.
   PubMed Web of Science ®Google Scholar
• LeGeros RZ. Properties of osteoconductive biomaterials: Calcium phosphates. Clin Orthop Relat Res, 2002;395:81–98.
   PubMed Web of Science ®Google Scholar
• Liberman UA, Weiss SR, Bröll J, Minne HW, Quan H, Bell NH, Rodriguez-Portales J, Downs RW, Jr, Dequeker J, Favus M. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. New N Engl J Med, 1995;333:1437–44.
   PubMed Web of Science ®Google Scholar
• Martins M, dos Santos C, Costa MEV, Almeida M. 2004. Preparation of porous hydroxyapatite particles to be used as drug delivery systems. Materials science forum. Switzerland: Trans Tech Publications Inc.
   Google Scholar
• Matsumoto T, Okazaki M, Inoue M, Yamaguchi S, Kusunose T, Toyonaga T, Hamada Y, Takahashi J. Hydroxyapatite particles as a controlled release carrier of protein. Biomaterials, 2004;25:3807–12.
   PubMed Web of Science ®Google Scholar
• Nancollas G, Tang R, Phipps R, Henneman Z, Gulde S, Wu W, Mangood A, Russell R, Ebetino F. Novel insights into actions of bisphosphonates on bone: Differences in interactions with hydroxyapatite. Bone, 2006;38:617–27.
   PubMed Web of Science ®Google Scholar
• Panda R, Hsieh M, Chung R, Chin T. FTIR, XRD, SEM and solid state NMR investigations of carbonate-containing hydroxyapatite nano-particles synthesized by hydroxide-gel technique. J Phys Chem Solids, 2003;64:193–9.
   Web of Science ®Google Scholar
• Rehman I, Bonfield W. Characterization of hydroxyapatite and carbonated apatite by photo acoustic FTIR spectroscopy. J Mater Sci Mater Med, 1997;8:1–4.
   PubMed Web of Science ®Google Scholar
• Russell R, Watts N, Ebetino F, Rogers M. Mechanisms of action of bisphosphonates: Similarities and differences and their potential influence on clinical efficacy. Osteoporos Int, 2008;19:733–59.
   PubMed Web of Science ®Google Scholar
• Shi X, Wang Y, Ren L, Gong Y, Wang DA. Enhancing alendronate release from a novel PLGA/hydroxyapatite microspheric system for bone repairing applications. Pharm Res, 2009a;26:422–30.
   PubMed Web of Science ®Google Scholar
• Shi X, Wang Y, Varshney RR, Ren L, Zhang F, Wang DA. In-vitro osteogenesis of synovium stem cells induced by controlled release of bisphosphate additives from microspherical mesoporous silica composite. Biomaterials, 2009b;30:3996–4005.
   PubMed Web of Science ®Google Scholar
• Ślósarczyk A, Paluszkiewicz C, Gawlicki M, Paszkiewicz Z. The FTIR spectroscopy and QXRD studies of calcium phosphate based materials produced from the powder precursors with different CaP ratios. Ceram Int, 1997;23:297–304.
   Web of Science ®Google Scholar
• Uskoković V, Uskoković DP. Nanosized hydroxyapatite and other calcium phosphates: Chemistry of formation and application as drug and gene delivery agents. J Biomed Mater Res B: Appl Biomater, 2011;96:152–91.
   PubMed Web of Science ®Google Scholar
• Xiong Y, Yang H, Feng J, Shi Z, Wu L. Effects of alendronate on the proliferation and osteogenic differentiation of MG-63 cells. J Int Med Res, 2009;37:407–16.
   PubMed Web of Science ®Google Scholar
• Xue W, Krishna BV, Bandyopadhyay A, Bose S. Processing and biocompatibility evaluation of laser processed porous titanium. Acta Biomater, 2007;3:1007–18.
   PubMed Web of Science ®Google Scholar
• Yang H, Hao L, Zhao N, Du C, Wang Y. Hierarchical porous hydroxyapatite microsphere as drug delivery carrier. Cryst Eng Comm, 2013;15:5760–3.
   Web of Science ®Google Scholar
• Zhang C, Li C, Huang S, Hou Z, Cheng Z, Yang P, Peng C, Lin J. Self-activated luminescent and mesoporous strontium hydroxyapatite nanorods for drug delivery. Biomaterials, 2010;31:3374–83.
   PubMed Web of Science ®Google Scholar
• Zhao XY, Zhu YJ, Qi C, Chen F, Lu BQ, Zhao J, Wu J. Hierarchical hollow hydroxyapatite microspheres: Microwave‐assisted rapid synthesis by using pyridoxal‐5′‐phosphate as a phosphorus source and application in drug delivery. Chem Asian J, 2013;8:1313–20.
   PubMed Web of Science ®Google Scholar
• Zhu YJ, Chen F. pH-responsive drug-delivery systems. Chem Asian J, 2015;10:284–305.
   PubMed Web of Science ®Google Scholar